Literature DB >> 18323566

Activated NF-kB in colorectal cancer: predictive or prognostic factor?

Giovanni Brandi, Maria A Pantaleo, Guido Biasco, Paola Paterini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18323566     DOI： 10.1200/JCO.2007.15.1845

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  4 in total

1.  KRAS mutation and NF-κB activation indicates tolerance of chemotherapy and poor prognosis in colorectal cancer.

Authors:  Gen Lin; Xiong-Wei Zheng; Chao Li; Qiang Chen; Yun-Bin Ye
Journal:  Dig Dis Sci       Date:  2012-04-24       Impact factor: 3.199

Review 2.  B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia.

Authors:  Michal Rihacek; Julie Bienertova-Vasku; Dalibor Valik; Jaroslav Sterba; Katerina Pilatova; Lenka Zdrazilova-Dubska
Journal:  Biomed Res Int       Date:  2015-08-03       Impact factor: 3.411

3.  Absence of DAB2IP promotes cancer stem cell like signatures and indicates poor survival outcome in colorectal cancer.

Authors:  Jiang Min; Liang Liu; Xiaolan Li; Jianwu Jiang; Jingtao Wang; Bo Zhang; Dengyi Cao; Dongdong Yu; Deding Tao; Junbo Hu; Jianping Gong; Daxing Xie
Journal:  Sci Rep       Date:  2015-11-13       Impact factor: 4.379

4.  Curcumol potentiates celecoxib-induced growth inhibition and apoptosis in human non-small cell lung cancer.

Authors:  Fangfang Cai; Minghui Chen; Daolong Zha; Peng Zhang; Xiangyu Zhang; Nini Cao; Jishuang Wang; Yan He; Xinxin Fan; Wenjing Zhang; Zhongping Fu; Yueyang Lai; Zi-Chun Hua; Hongqin Zhuang
Journal:  Oncotarget       Date:  2017-12-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.